People · Operator
Named in public records as an officer, director or promoter · active 2018–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Calviri Inc | — | Biotechnology | Series A | $17.4M | $3.5M | 2018 |
Kathryn Albert Sykes at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kathryn Albert Sykes on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jacque J. Sokolov | 1 | 4 |
| Jeffrey J. Le Benger | 1 | 1 |
| Michael J. McCallister | 1 | 1 |
| Stephen Albert Johnston | 1 | 1 |
| Michael J. Chambers | 1 | 1 |
| Jeff J. Le Benger | 1 | 1 |
| Marc J. Wolff | 1 | 1 |
| George Albert Poste | 1 | 1 |
| Neal Albert Woodbury | 1 | 1 |
| Anna Albert Barker | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.